{
  "success": true,
  "pagesUsed": [
    6,
    7,
    9,
    10,
    14,
    15,
    16,
    17,
    19,
    22,
    23,
    24,
    36,
    38,
    46,
    56,
    58,
    59
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": {
          "id": "ac897e7b-8927-4fe6-b268-3de78874e166",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "b76a534c-ddb1-432d-82e1-71e81cdaeaf2",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "c84d84df-8893-41f6-be7d-11371a691b8a",
        "instanceType": "Timing",
        "windowLower": "-P28D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_2",
        "name": "Cycle 1 Day 1 Visit Window",
        "type": {
          "id": "22f3e2a9-9fcb-49ad-9764-badebcf6dcbc",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "Day 1",
        "relativeToFrom": {
          "id": "12e3d372-afd0-430e-bcac-9f3471d8aa0a",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "073d2af7-925a-4b93-9678-eb2246bc5f15",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_3",
        "name": "Cycle 1 Day 15 Visit Window",
        "type": {
          "id": "27712344-5319-4fc4-b8c2-50304b491e4e",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P15D",
        "valueLabel": "Day 15",
        "relativeToFrom": {
          "id": "5993fe43-a2d9-4a97-8f7e-0d7bc51a4de6",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "f3fed3e8-b913-480b-b0ab-a87527ecfbbb",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_4",
        "name": "Cycles >=3 Day 1 Visit Window",
        "type": {
          "id": "9e5bba46-2956-4a47-92d9-f187bc29b98c",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "Day 1",
        "relativeToFrom": {
          "id": "fc0e9b4c-a61f-4595-b6e8-55afd465d445",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "6ebd68fa-4883-43ac-a4ef-249926a5494b",
        "instanceType": "Timing",
        "windowLower": "-P7D",
        "windowUpper": "P7D"
      },
      {
        "id": "timing_5",
        "name": "Fulvestrant Dosing Interval (Post-Cycle 1)",
        "type": {
          "id": "f8082d4e-d64a-4d80-906f-c33ca581368b",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "424df9c3-e5f0-48fb-aea4-2caf004d9d4e",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "5a4f556c-9fd3-4316-aa3e-dc0ebd50dfea",
        "instanceType": "Timing",
        "windowLower": "-P7D",
        "windowUpper": "P7D"
      },
      {
        "id": "timing_6",
        "name": "Palbociclib Dosing Schedule",
        "type": {
          "id": "b5105b89-2af6-4efb-8559-903feb2dd82f",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P21D",
        "valueLabel": "Day 21",
        "relativeToFrom": {
          "id": "2626b286-b707-442c-a61f-72614347a75e",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "8709f8b3-d09e-42e8-9926-b1e8d0234aa7",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_7",
        "name": "Goserelin Pre-treatment Requirement",
        "type": {
          "id": "40e51828-ea49-4350-a4b6-39bc7b7c0ab6",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P4W",
        "valueLabel": "4 weeks",
        "relativeToFrom": {
          "id": "db58e8c7-49a0-4a00-b1dd-ec9fdaead702",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "9fddb7cf-4f0c-43e0-8d38-576cd7637a6a",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_8",
        "name": "Goserelin Dosing Interval",
        "type": {
          "id": "41d52b86-fa6e-4aa0-8638-47d18ac2a256",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "da016c5b-03c6-44fe-8dec-89aaf6fcb08c",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "732fbf97-53fb-41bd-a698-71a9a7c827a8",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_9",
        "name": "End of Treatment Visit",
        "type": {
          "id": "48d18648-73df-4598-b84a-bc21525b912f",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P4W",
        "valueLabel": "4 weeks",
        "relativeToFrom": {
          "id": "8eaeec1a-e224-4048-940f-3ad930c333e5",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "878a8167-78b3-4ea2-8671-050ae795ec3d",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_10",
        "name": "Post-Treatment AE Follow-up",
        "type": {
          "id": "6d26619b-6b95-4adc-9b27-c60d36080ef2",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P28D",
        "valueLabel": "Day 28",
        "relativeToFrom": {
          "id": "5dd43604-8449-415b-8d39-13161d6f054a",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "253a2f4b-f648-485e-a92c-f2e0fc6e7846",
        "instanceType": "Timing",
        "windowLower": "-P7D",
        "windowUpper": "P7D"
      },
      {
        "id": "timing_11",
        "name": "Survival Follow-up Interval",
        "type": {
          "id": "d3a02cf0-a311-4482-92f3-d6680bd34783",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P3D",
        "valueLabel": "3 months",
        "relativeToFrom": {
          "id": "fafc672b-1f90-462e-bc6f-a8e74e9f3309",
          "code": "C71156",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Last Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "9b1be2a6-9d0c-411d-a7f1-b7d68db27778",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_12",
        "name": "Cycle 1 Day 1 Assessment Window",
        "type": {
          "id": "91fd34b0-8a11-4280-b3c3-ba831150a99d",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P7D",
        "valueLabel": "Day 7",
        "relativeToFrom": {
          "id": "ee08e86d-ec05-491e-897b-377bc0b90028",
          "code": "C71154",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Randomization",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "d4ea3cde-4dc1-454d-a9c4-fca300d60bd1",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_13",
        "name": "Ophthalmic Exam Schedule",
        "type": {
          "id": "7cf8a405-444a-469e-b352-a95d6433d548",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P0D",
        "valueLabel": "Ophthalmic Exam Schedule",
        "relativeToFrom": {
          "id": "8796de98-fe8c-45cc-aaa9-484a7c8ac2a8",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "0a526fec-e45b-4b60-92c8-743b2d9ab2d9",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_14",
        "name": "Blood Chemistry Interval (Cycles >=7)",
        "type": {
          "id": "6b0ee26e-753b-45b0-b290-4bc453f7feea",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P3D",
        "valueLabel": "3 cycles",
        "relativeToFrom": {
          "id": "955129da-7128-4b8b-96f4-11387280cd11",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "ae9e8eb7-31bf-4e5a-849c-260295971d60",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_15",
        "name": "SAE Reporting Period",
        "type": {
          "id": "bda34776-d92d-457b-8194-95523513b875",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P0D",
        "valueLabel": "SAE Reporting Period",
        "relativeToFrom": {
          "id": "cac64d23-a1aa-4ab9-9f43-a67632625974",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "8c528383-e4f9-4557-b383-9cd035713f28",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Fulvestrant Dosing Hold Criteria",
        "instanceType": "Condition",
        "description": "Condition under which fulvestrant should not be administered.",
        "text": "Fulvestrant should not be administered if the platelet count is <50,000/mm3."
      },
      {
        "id": "cond_2",
        "name": "Palbociclib Retreatment Criteria",
        "instanceType": "Condition",
        "description": "Criteria that must be met before resuming palbociclib/placebo after an interruption or at the start of a new cycle.",
        "text": "Platelet count >=50,000/mm3; ANC >=1000/mm3 and no fever; Grade >=3 non-hematologic AEs recovered to Grade <=1 or baseline; QTc <=500 msec."
      },
      {
        "id": "cond_3",
        "name": "Palbociclib Dose Reduction Trigger",
        "instanceType": "Condition",
        "description": "Toxicity criteria that trigger a dose reduction for subsequent cycles.",
        "text": "In case of a Grade 2 toxicity lasting for >3 weeks or a Grade >=3 toxicity (both assessed in the presence of maximum supportive care as judged by the investigator), dose reduction is recommended for the subsequent cycles."
      },
      {
        "id": "cond_4",
        "name": "Sensitivity to Prior Hormonal Therapy Definition",
        "instanceType": "Condition",
        "description": "Definition used for patient stratification.",
        "text": "Sensitivity to prior hormonal therapy is defined as either: (i) Documented clinical benefit (CR, PR, SD >=24 weeks) to at least one prior hormonal therapy in the metastatic setting, OR (ii) At least 24 months of adjuvant hormonal therapy prior to recurrence."
      },
      {
        "id": "cond_5",
        "name": "Progression on Prior Endocrine Therapy",
        "instanceType": "Condition",
        "description": "Eligibility criterion related to disease progression on prior therapy.",
        "text": "disease has progressed during or within 12 months of completion of adjuvant therapy... or progressed while on, or within 1 month after the end of prior therapy for advanced/metastatic breast cancer"
      },
      {
        "id": "cond_6",
        "name": "E-DMC Safety Review Trigger",
        "instanceType": "Condition",
        "description": "Condition for the external data monitoring committee to perform an early safety review.",
        "text": "An external data monitoring committee (E-DMC) will perform an early review of safety data from approximately the first 40 randomized patients with sufficient pharmacokinetic (PK) sampling to confirm safety and tolerability of the combination."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Continuation Post-Progression",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "fromElementId": "active_treatment",
        "toElementId": "active_treatment_post_pd",
        "text": "Patients showing PD can continue with study treatment at the discretion of the investigator as long as that is considered to be in the best interest of the patient and no new anticancer treatment is initiated."
      },
      {
        "id": "trans_2",
        "name": "Partial Discontinuation for Toxicity",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "fromElementId": "palbociclib_treatment",
        "toElementId": "fulvestrant_monotherapy",
        "text": "should palbociclib/placebo related toxicity mandate palbociclib/placebo discontinuation, patients can continue to receive fulvestrant alone."
      },
      {
        "id": "trans_3",
        "name": "Transition to Follow-up Phase",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "active_treatment",
        "toElementId": "follow_up",
        "text": "Patients discontinuing the active treatment phase (ie, discontinuing both palbociclib/placebo and fulvestrant) will enter a follow-up phase during which survival and new anti-cancer therapy information will be collected."
      },
      {
        "id": "trans_4",
        "name": "Fulvestrant Dose Delay",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Treatment delay for fulvestrant-related toxicities will be performed as per the investigatorâ€™s best medical judgment, but by no more than 7 days."
      },
      {
        "id": "trans_5",
        "name": "Fulvestrant Dose Skip",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If delay of longer than 7 days is required then the dose should be skipped."
      },
      {
        "id": "trans_6",
        "name": "Palbociclib Discontinuation for Delayed Recovery",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "If these parameters [retreatment criteria] have not been met after 3 weeks of dosing interruption, the patient should permanently discontinue palbociclib/placebo treatment."
      },
      {
        "id": "trans_7",
        "name": "Palbociclib Dose Reduction",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Dose reduction of palbociclib/placebo by one, and, if needed, by two dose levels is recommended depending on type and severity of the toxicity."
      },
      {
        "id": "trans_8",
        "name": "Palbociclib Schedule Change",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Patients requiring more than two dose reductions will be allowed to receive 75 mg/day for 2 weeks on followed by 2 weeks off study treatment."
      },
      {
        "id": "trans_9",
        "name": "No Dose Re-escalation",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Once a dose has been reduced for a given patient, all subsequent cycles should be administered at that dose level... Dose re-escalation is not allowed."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Treatment Discontinuation Criteria",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Criteria for discontinuing assigned study treatment."
      },
      {
        "id": "exit_2",
        "name": "Palbociclib Discontinuation for Delayed Recovery",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Permanent discontinuation of palbociclib if recovery from toxicity takes too long."
      },
      {
        "id": "exit_3",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Patient completes the study after finishing treatment and all follow-up."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Continuation Post-Progression Decision",
        "timepointId": "tumor_assessment",
        "instanceType": "ScheduledDecisionInstance",
        "description": "At the time of objective Progressive Disease, the investigator decides whether to continue study treatment."
      },
      {
        "id": "dec_2",
        "name": "Palbociclib Retreatment Decision",
        "timepointId": "cycle_start",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision at the start of a new cycle or after a treatment interruption to resume palbociclib, based on retreatment criteria.",
        "conditionIds": [
          "cond_2"
        ]
      },
      {
        "id": "dec_3",
        "name": "Palbociclib Dose Modification Decision",
        "timepointId": "end_of_cycle",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision to reduce palbociclib dose for the next cycle based on toxicity experienced in the current cycle.",
        "conditionIds": [
          "cond_3"
        ]
      }
    ],
    "summary": {
      "timingCount": 15,
      "conditionCount": 6,
      "transitionRuleCount": 9,
      "exitCount": 3
    }
  }
}